Abeona Therapeutics Inc (ABEO)
4.29
-0.02
(-0.46%)
USD |
NASDAQ |
May 22, 16:00
4.30
+0.01
(+0.23%)
After-Hours: 20:00
Abeona Therapeutics Research and Development Expense (Quarterly): 7.207M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.207M |
| December 31, 2023 | 7.379M |
| September 30, 2023 | 7.148M |
| June 30, 2023 | 8.523M |
| March 31, 2023 | 8.041M |
| December 31, 2022 | 6.272M |
| September 30, 2022 | 5.49M |
| June 30, 2022 | 6.658M |
| March 31, 2022 | 10.54M |
| December 31, 2021 | 12.80M |
| September 30, 2021 | 9.056M |
| June 30, 2021 | 8.533M |
| March 31, 2021 | 8.317M |
| December 31, 2020 | 9.243M |
| September 30, 2020 | 7.969M |
| June 30, 2020 | 6.109M |
| March 31, 2020 | 6.818M |
| December 31, 2019 | 9.605M |
| September 30, 2019 | 10.92M |
| June 30, 2019 | 16.31M |
| March 31, 2019 | 11.74M |
| December 31, 2018 | 9.47M |
| September 30, 2018 | 13.15M |
| June 30, 2018 | 7.916M |
| March 31, 2018 | 8.162M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.706M |
| September 30, 2017 | 3.277M |
| June 30, 2017 | 5.808M |
| March 31, 2017 | 2.198M |
| December 31, 2016 | 3.037M |
| September 30, 2016 | 2.745M |
| June 30, 2016 | 3.018M |
| March 31, 2016 | 1.855M |
| December 31, 2015 | 2.071M |
| September 30, 2015 | 1.581M |
| June 30, 2015 | 0.61M |
| March 31, 2015 | 0.453M |
| December 31, 2014 | 0.035M |
| September 30, 2014 | 0.073M |
| June 30, 2014 | 0.081M |
| March 31, 2014 | 0.144M |
| December 31, 2013 | 0.128M |
| September 30, 2013 | 0.236M |
| June 30, 2013 | 0.197M |
| March 31, 2013 | 0.323M |
| December 31, 2012 | 0.298M |
| September 30, 2012 | 0.308M |
| June 30, 2012 | 0.654M |
| March 31, 2012 | 0.75M |
| December 31, 2011 | 0.757M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
5.49M
Minimum
Sep 2022
16.31M
Maximum
Jun 2019
8.647M
Average
8.179M
Median
Research and Development Expense (Quarterly) Benchmarks
| T2 Biosystems Inc | 3.721M |
| INVO Bioscience Inc | 0.0049M |
| Perspective Therapeutics Inc | 7.452M |
| Electromed Inc | 0.167M |
| Xtant Medical Holdings Inc | 0.527M |